These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10406682)

  • 1. Coated stents: local pharmacology.
    Raman VK; Edelman ER
    Semin Interv Cardiol; 1998; 3(3-4):133-7. PubMed ID: 10406682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory stent coatings: dexamethasone and related compounds.
    Park SH; Lincoff AM
    Semin Interv Cardiol; 1998; 3(3-4):191-5. PubMed ID: 10406692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local paclitaxel delivery after coronary stenting in an experimental animal model.
    Dommke C; Haase KK; Süselbeck T; Streitner I; Haghi D; Metz J; Borggrefe M; Herdeg C
    Thromb Haemost; 2007 Sep; 98(3):674-80. PubMed ID: 17849059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local methylprednisolone delivery using a BiodivYsio phosphorylcholine-coated drug-delivery stent reduces inflammation and neointimal hyperplasia in a porcine coronary stent model.
    Huang Y; Liu X; Wang L; Verbeken E; Li S; De Scheerder I
    Int J Cardiovasc Intervent; 2003; 5(3):166-71. PubMed ID: 12959735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the heparin coated vs the uncoated Jostent--no influence on restenosis or clinical outcome.
    Wöhrle J; Al-Khayer E; Grötzinger U; Schindler C; Kochs M; Hombach V; Höher M
    Eur Heart J; 2001 Oct; 22(19):1808-16. PubMed ID: 11549303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative pathology: radiation-induced coronary artery disease in man and animals.
    Virmani R; Farb A; Carter AJ; Jones RM
    Semin Interv Cardiol; 1998; 3(3-4):163-72. PubMed ID: 10406688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
    Grube E; Buellesfeld L
    Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylcholine-coated stents.
    Lewis AL; Stratford PW
    J Long Term Eff Med Implants; 2002; 12(4):231-50. PubMed ID: 12627785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local vascular toxicokinetics of stent-based drug delivery.
    Tesfamariam B
    Toxicol Lett; 2007 Jan; 168(2):93-102. PubMed ID: 17169513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of subacute stent thrombosis (SAT) using heparin-coated stents in a large-scale, real world registry.
    Gupta V; Aravamuthan BR; Baskerville S; Smith SK; Gupta V; Lauer MA; Fischell TA
    J Invasive Cardiol; 2004 Jun; 16(6):304-10. PubMed ID: 15155999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents.
    Ajani AE; Yan BP; Clark DJ; Eccleston D; Walton A; Lew R; Meehan A; Brennan A; Reid C; Duffy SJ;
    Heart Lung Circ; 2007 Aug; 16(4):269-73. PubMed ID: 17419097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
    Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.
    New G; Moses JW; Roubin GS; Leon MB; Colombo A; Iyer SS; Tio FO; Mehran R; Kipshidze N
    Catheter Cardiovasc Interv; 2002 Oct; 57(2):266-71. PubMed ID: 12357534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of molecular events in coronary restenosis using coated stents: The Mayo Clinic Approach.
    Keelan PC; Miyauchi K; Caplice NM; Ashai KH; Schwartz RS
    Semin Interv Cardiol; 1998; 3(3-4):211-5. PubMed ID: 10406696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
    Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
    Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of the Jostent coronary stent graft implantation in various clinical settings: procedural and follow-up results.
    Gercken U; Lansky AJ; Buellesfeld L; Desai K; Badereldin M; Mueller R; Selbach G; Leon MB; Grube E
    Catheter Cardiovasc Interv; 2002 Jul; 56(3):353-60. PubMed ID: 12112888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particle debris from a nanoporous stent coating obscures potential antiproliferative effects of tacrolimus-eluting stents in a porcine model of restenosis.
    Kollum M; Farb A; Schreiber R; Terfera K; Arab A; Geist A; Haberstroh J; Wnendt S; Virmani R; Hehrlein C
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):85-90. PubMed ID: 15619311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo distribution of c-myc antisense oligodeoxynucleotides local delivered by gelatin-coated platinum-iridium stents in rabbits and its effect on apoptosis.
    Zhang XX; Cui CC; Xu XG; Hu XS; Fang WH; Kuang BJ
    Chin Med J (Engl); 2004 Feb; 117(2):258-63. PubMed ID: 14975213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.